Therefore, although clarifying the association between GJA4 c.121G > T (p.Gly41Cys) and established signaling pathways is warranted, the hyperactive hemichannel should be considered as an additional therapeutic target for vascular malformations. The gene discussed is GJA4; the disease is vascular malformation.